510(k) clearance pitfalls — the weak links that actually stall approval

The article says 510(k) delays often come from weak documentation, not device performance problems.

Common FDA review blockers include predicate mismatches, thin V&V evidence, and incomplete risk management.

Missing human factors, biocompatibility, software, cybersecurity, sterilization, and packaging data can stall review.

Poor supplier controls and weak traceability between claims, design controls, and testing also trigger hold letters.